Erfa HQ 4% Gel
Originaltext auf Französisch.
In Kanada zugelassenes natürliches Gesundheitsprodukt
Die Analyse oraler Dosen ist ohne einen nachgewiesenen ausschließlich oralen Verabreichungsweg nicht anwendbar.
Zusammensetzung
| Arzneilicher Inhaltsstoff und Quelle | Je Dosiseinheit laut Quelle |
|---|---|
| 1,4-Benzènediol Quelle : Hydroquinone | 4 % |
Nicht arzneiliche Inhaltsstoffe
NA, Ethanol, Poly(quaternium-10), Propylène glycol, Sulfite de sodium, Edétate disodique, Hydroxytoluène butylé, Acide glycolique, Eau purifiée, Solution d'ammoniac concentrée, Métabisulfite de sodium
In Kanada empfohlene Dosen
| Bevölkerungsgruppe | Alter | Menge pro Einnahme | Häufigkeit |
|---|---|---|---|
| Adultes | Non précisée | 1 Gel | minimum : 1 Tous les jours ; maximum : 2 Tous les jours |
In Kanada zugelassene Verwendungen
To lighten hyperpigmented skin, fade skin discolorations and lighten freckles and age spots.
Originaltext auf Französisch.
Eine in Kanada zugelassene Verwendung ist keine in der Europäischen Union zugelassene gesundheitsbezogene Angabe. Beachten Sie das Register gesundheitsbezogener Angaben.
Warnhinweise in Kanada
Précautions et mises en garde : To be used only on the advice of a physician. For external use only. Avoid contact with eyes, mucous membranes and broken or irritated skin. In case of contact, rinse thoroughly with water. Test for sensitivity. Apply only to small skin surface area. Discontinue use and consult a physician in case of skin reactions or a blue-black darkening of the skin. Use only as directed. Do not apply over sunburn or irritated skin. Keep out of reach of children. Avoid direct sun exposure. In case of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately. Store at room temperature. To test for sensitivity, before treatment, apply to an area of approximately 1 cm2 of unbroken skin on the inside of the arm. If no irritation occurs within 24 hours, begin treatment for up to 12 weeks. The safety of topical hydroquinone use during pregnancy or children 12 years old or less has not been established. Hydroquinone is a skin bleaching agent which may produce unwanted cosmetic effects if not used as directed. The physician should be familiar with the contents of this insert before prescribing or dispensing this product. Close patient supervision is recommended. Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure may cause skin re-darkening. Treatment should be limited to relatively small areas of the body at one time. Note: Slight darkening of the product is normal when exposed to air and does not affect its potency. When this happens, extract a tiny amount of product, clean with a cotton swab and discard prior to use. If the entire contents become brown, discontinue use and consult a physician. This product contains glycolic acid and citric acid, which are alpha-hydroxy acids (AHAs) which may increase skin's sensitivity to the sun and particularly the possibility of sunburn. It is recommended that prior to exposure to the sun, users cover areas where AHAs have been applied with sunscreen. Contact of the product with the skin must be limited frequency or duration. Contains sodium metabisulfite, a sulfite which may cause serious allergic type reactions (e.g. hives, itching, wheezing, anaphylaxis, severe asthma attacks) in certain persons.
Originaltext auf Französisch.
Effets indésirables connus : A mild transient stinging or minor redness may occur in people with sensitive skin. Discontinue use in case of irritation, rash, excessive inflammatory response or if gradual blue-black darkening of the skin (exogenous ochronosis) occurs. Minor redness is acceptable, but where there is an excessive irritation, a rash or other reaction, further treatment is not advised. Severe itching or reddening may occur, in which case the product should be discontinued and the physician notified immediately. A bitter taste and anesthetic effect may occur if applied to lips.
Originaltext auf Französisch.
Contre-indications : Do not use this product if you are nursing, pregnant or if you intend to become pregnant within 3 months of use. Not for use on children. Do not use this product if you have used it or any of its ingredients before and skin sensitivity or irritation has occurred. If you have a family history or, have or have had or at risk of developing cancer, do not use.
Originaltext auf Französisch.
Produktdaten
- Inhaber
- Erfa Canada 2012 Inc.
- NPN oder DIN-HM
- 80068828
- Status
- Lizenz nicht aktiv
- Lizenzdatum
- 25. April 2016
- Überarbeitungsdatum
- Nicht angegeben
- Form
- Gel
- Verabreichungsweg
- Topique
- Art des Antrags
- Non traditionnelle
Quelle
Amtlicher Health-Canada-Eintrag, Zulassung 80068828
Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise, abgerufen am 27. Oktober 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Originaltext auf Englisch.
Originaltext auf Französisch.
Die unter demselben Namen in Europa verkaufte Rezeptur kann abweichen. Diese Angaben ersetzen keinen ärztlichen oder pharmazeutischen Rat.
Das Belegdatum dieser Zutatenliste ist unbekannt.
Das Produkt hat sich geändert? Fotografieren Sie die Verpackung.
Ist eine Angabe zu diesem Produkt falsch oder veraltet, ob Sie Leser oder Marke sind? Schreiben Sie an contact@compoatlas.com: Jede Korrektur wird im Korrekturprotokoll veröffentlicht.